Trending...
- LIGUORI ACADEMY- KRAVINSKY LITERACY PROGRAM FOUNDED BY PHILANTHROPIST, ZELL KRAVINSKY
- SIGLENT Technologies Expands the Addressable Frequency Range of its RF Instruments to Best Support Microwave Range
- KiwiQA chosen as the preferred testing vendor by Stone & Chalk, leading Australia-based innovation Start-up & scaleup hub
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Sema4 Holdings Corp. ("Sema4" or the "Company") (NASDAQ: SMFR, SMFRW) investors concerning the Company's possible violations of federal securities laws.
On July 22, 2021, CM Life Sciences, Inc., a special purpose acquisition company, completed its business combination with Mount Sinai Genomics, Inc., and the combined public entity was renamed Sema4.
More on The PennZone
Less than a year later, on June 14, 2022, Sema4 announced that its Chief Financial Officer had departed.
Then, on August 15, 2022, after the market closed, Sema4 announced changes to its research and development leadership team, including that its founder was stepping down from the organization and leaving his role as President and Chief R&D Officer. The Company also disclosed that it was eliminating approximately 13% of its workforce as part of a series of restructuring and corporate realignments. Additionally, Sema4 lowered its fiscal 2022 revenue guidance to $245 million to $255 million from its prior guidance of $305 million to $315 million.
On this news, Sema4's stock fell $0.80, or 33.3%, to close at $1.60 per share on August 16, 2022, thereby injuring investors.
If you purchased Sema4 securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.
More on The PennZone
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com
On July 22, 2021, CM Life Sciences, Inc., a special purpose acquisition company, completed its business combination with Mount Sinai Genomics, Inc., and the combined public entity was renamed Sema4.
More on The PennZone
- Statement Pursuant to Section 19(a) of the Investment Company Act of 1940: DEX
- Pennsylvania: Gov. Wolf Signs Legislation Extending Authority of State Horse Racing Commission
- Gov. Wolf: More Than 1.7 Million Pennsylvanians Eligible for Relief on Student Loans
- Ironside Human Resources Announces Office Expansion Due to Rapid Growth
- Gov. Wolf Reminds Pennsylvanians to Explore Affordable Health Care Options through Pennie Ahead of Open Enrollment Period
Less than a year later, on June 14, 2022, Sema4 announced that its Chief Financial Officer had departed.
Then, on August 15, 2022, after the market closed, Sema4 announced changes to its research and development leadership team, including that its founder was stepping down from the organization and leaving his role as President and Chief R&D Officer. The Company also disclosed that it was eliminating approximately 13% of its workforce as part of a series of restructuring and corporate realignments. Additionally, Sema4 lowered its fiscal 2022 revenue guidance to $245 million to $255 million from its prior guidance of $305 million to $315 million.
On this news, Sema4's stock fell $0.80, or 33.3%, to close at $1.60 per share on August 16, 2022, thereby injuring investors.
If you purchased Sema4 securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.
More on The PennZone
- Aspirant Announces New Organizational Effectiveness Principal
- Evangeline M. Mitchell Named as the Recipient of the Bar Association of DC's 150th Anniversary Presidential Award
- Qurate Retail Group Names Scott Barnhart Chief Operating Officer
- Corrupt Nypd Official Captured On Camera
- Grammy® Nominated Duo Helen Bruner & Terry Jones New Single & Visuals For "At Dinner 32"
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com
Filed Under: Business
0 Comments
Latest on The PennZone
- Gov. Wolf's $25 Million State Child Care Tax Credit Will Support 221,000 Working Families in Pennsylvania
- Lincoln Financial Group to Report Third Quarter Earnings
- The Democracy Group launches fellowship for aspiring Gen Z podcasters
- Sydney Brachytherapy Group is the first private non-melanoma skin cancer clinic in Sydney to offer OncoBeta's Rhenium-SCT
- UnityLab Secures $4.5 Million Series A Funding to Accelerate Growth, Add Jobs and Expand Manufacturing Operations in Dushore, Pennsylvania
- PermaTherm Announces Panels Delivered Quickly Program
- ASI Hosts 24th Annual iNNOVATIONS Conference and Announces Award Winners
- Myonex Launches CTRx Europe, Central Pharmacy Network
- MolecuLight Point-of-Care Wound Imaging Devices Awarded Group Purchasing Agreement with AllSpire Health GPO
- Cantaloupe, Inc. to Delay Form 10-K Filing for Fiscal Year 2022
- Hundreds Walk For Recovery, Jobs A Solution
- The World's First Stuttering Mentalist - Johnathan Smith Is A Story Of Determination And Hard Work
- Pennsylvania: Gov. Wolf Announces Deployment of PA-Task Force 1 to Support Hurricane Ian Response
- InHome Therapy Announces $22 Million Investment Led by TT Capital Partners to Fuel Growth and Expansion
- BEAR Technologies Successfully Completes 2022 SOC 2 Type II Audit
- Exterro Launches FTK® Suite 7.6, Introducing Mobile Parsing, Automation Capabilities, And Industry-First Remote Endpoint Triage
- Kitchen Magic Adopts Zero-Waste-to-Landfill Initiative
- Pennsylvania: Gov. Wolf, Lt. Gov. Fetterman: Time is Running Out for People Interested in Quick Pardons through PA Marijuana Pardon Project
- AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2022 Earnings Release
- Re-Introducing Gigahurtz, DJ and Producer